Number of the records: 1
喹唑啉化合物
- 1.
SYSNO ASEP 0534384 Document Type P - Patent R&D Document Type Patent or other outcome protected by special legislation Title 喹唑啉化合物 Title Quinazoline compounds Author(s) Jansa, Petr (UOCHB-X) RID
Šimon, Petr (UOCHB-X) ORCID
Lansdon, E. (US)
Hu, Y. E. (US)
Baszczyňski, Ondřej (UOCHB-X) RID, ORCID
Dejmek, Milan (UOCHB-X) RID, ORCID
Mackman, R. (US)Year of issue 2020 Possible third party use of the result A - Pro využití výsledku jiným subjektem je vždy nutné nabytí licence Royalty requested A - Poskytovatel licence požaduje licenční poplatek Patent no. or utility model no. or industrial design no. TWI699355 Date of the patent acceptance 21.07.2020 Name of the patent owner Gilead Sciences, Inc. - Ústav organické chemie a biochemie AV ČR, v. v. i Code of the issuer name CN002 - Patent Office - State Intellectual Property Office of the Peoples Republic of China (SIPO) Beijing Current use A - Pouze udělený (dosud nevyužívaný) patent nebo patent využívaný jeho vlastníkem Language chi - Chinese Keywords quinazoline ; reverse transcriptase ; antiviral ; NNRTI Subject RIV CC - Organic Chemistry OECD category Organic chemistry Institutional support UOCHB-X - RVO:61388963 Annotation 本發明所述為化學式 (I) 的化合物及其互變異構物與其藥學鹽、 含有此等化合物的組合物及製劑， 以及使用及製造此等化合物的方法。 Description in English Described herein are compounds of Formula (I) and tautomers and pharmaceutical salts thereof, compositions and formulations containing such compounds, and methods of using and making such compounds. Workplace Institute of Organic Chemistry and Biochemistry Contact asep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Jana Procházková, Tel.: 220 183 418 Year of Publishing 2021 Electronic address https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=TW&NR=I699355B&KC=B&FT=D&ND=4&date=20200721&DB=&locale=en_EP
Number of the records: 1